A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Valneva (VALN) announced results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different ...

Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...

Researchers believe the innovative idea holds immense promise for tackling a wide range of diseases including cancer through ...